To the Editor: In the last year, the issue of cardiotoxicity of imatinib mesylate (IM) was on
focus. After the original work from Kerkelä et al.[1], various papers reported a low incidence …

A total of 186 patients with primary myelofibrosis (PMF) were genotyped for JAK2 V617F at
diagnosis aimed at analyzing the correlation of mutational status and mutated allele burden …

ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …

Myeloproliferative neoplasms (MPNs) are a heterogeneous group of leukemias with
defective regulation of myeloid stem cell proliferation. They include four distinct diseases …

We recently reported that using plasma rather than peripheral blood cells improves
detection of the JAK2 V617F mutation, 1 which is the most important characteristic molecular …

Background: Primary and secondary [post-essential thrombocythemia (ET) or polycythemia
vera (PV)] Myelofibrosis (MF) are clonal hematopoietic neoplasms marked by constitutive …

Dear Editor, Myelofibrosis is a Philadelphia chromosome-negative chronic
myeloproliferative neoplasm characterized by development of bone marrow fibrosis …

JAK2-V617F and BCR-ABL--double jeopardy? - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

We screened 136 patients with myelofibrosis and a median age of 58 years who underwent
allogeneic stem cell transplantation (AHSCT) for molecular residual disease for JAKV617F …

2 Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation.
J Clin Oncol 1994; 12: 1710–1717. 3 Mortimer J, Blinder MA, Schulman S, Appelbaum FR …